Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients
Public ClinicalTrials.gov record NCT01603082. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-label Study to Compare the Platelet Inhibition With VerifyNow Assay of Ticagrelor Versus Clopidogrel in Troponin Negative Acute Coronary Syndrome Subjects Undergoing Ad Hoc Percutaneous Coronary Intervention
Study identification
- NCT ID
- NCT01603082
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 343 participants
Conditions and interventions
Conditions
Interventions
- Ticagrelor Drug
- Clopidogrel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2012
- Primary completion
- May 31, 2014
- Completion
- May 31, 2014
- Last update posted
- Dec 10, 2015
2012 – 2014
United States locations
- U.S. sites
- 16
- U.S. states
- 15
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | San Francisco | California | — | — |
| Research Site | Washington D.C. | District of Columbia | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Ypsilanti | Michigan | — | — |
| Research Site | Minneapolis | Minnesota | — | — |
| Research Site | Tupelo | Mississippi | — | — |
| Research Site | North Kansas City | Missouri | — | — |
| Research Site | Belleville | New Jersey | — | — |
| Research Site | New York | New York | — | — |
| Research Site | The Bronx | New York | — | — |
| Research Site | Greensboro | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Tyler | Texas | — | — |
| Research Site | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01603082, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 10, 2015 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01603082 live on ClinicalTrials.gov.